Halozyme Therapeutics, Inc. (HALO) — closed signal from September 16, 2025
Partial Published before the outcome was known, scored automatically when the window closed on December 15, 2025.
Predicted vs. what happened
What happened
Reached 20% of the predicted growth at its peak, without hitting the target.
The thesis — published September 16, 2025
Halozyme earns steady royalties from partners, giving it a dependable growth path. One short-term signal looks weak, but the recent average price is trending up and the stock looks washed out, making pullbacks attractive. Recent notes say the shares look cheaper than peers, it holds a top Zacks rating, and price strength is building, so a higher value is possible. Partner launches and royalties can support gains over the next 3 months.
Primary drivers
- Uptrend in recent average price and a tired selloff make dips appealing
- Recent reports highlight a bargain price and a top Zacks ranking
- Royalties from partners bring in predictable cash month after month
- Steady price strength keeps investors engaged and can draw new buyers
How it played out
HALO: target was not reached
Lyra published HALO on 2025-09-16 at $75.96 with expected growth of 24% and a $94.19 target. The thesis pointed to steady partner royalties, an improving recent average price, a tired selloff, cheaper-than-peer notes, a top Zacks rating, partner launches, and price strength that could draw buyers over the next 3 months.
Inside the window, HALO peaked at $79.50 on 2025-09-23, for a peak gain of 4.7%. It never reached $94.19. By 2025-12-15, it ended at $63.45. The thesis only partially played out at the start, then missed.
What happened during the window
On 2025-11-03, Halozyme reported third-quarter results. Investors.com reported profit of $1.72 a share, revenue of $354 million, and royalty revenue of $236 million. On 2025-11-21, Investors.com reported that management had raised its full-year 2025 earnings and revenue guidance.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.